RedHill Biopharma Fundamental Relationships

RDHL -- Israel Stock  

ILS 308.40  12.00  4.05%

The Drivers Module shows relationships between RedHill Biopharma's most relevant fundamental drivers and provides multiple suggestions of what could possibly affect the performance of RedHill Biopharma Ltd over time as well as its relative position and ranking within its peers. Additionally take a look at Your Equity Center.

RedHill Biopharma Current Ratio vs. Return On Asset Fundamental Analysis

RedHill Biopharma Ltd is rated below average in return on asset category among related companies. It is currently regarded as top stock in current ratio category among related companies .
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
RedHill Biopharma 
Return on Asset 
 = 
Net Income 
Total Assets 
X
100 
=
(54.98) %
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
RedHill Biopharma 
Current Ratio 
 = 
Current Asset 
Current Liabilities 
=
4.20 times
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e. Current Ration of 2 to 1).

RedHill Biopharma Current Ratio Comparison

  Current Ratio 
      RedHill Biopharma Comparables 
RedHill Biopharma is currently under evaluation in current ratio category among related companies.
  Revenue 
      RedHill Biopharma Comparables 
RedHill Biopharma is currently under evaluation in revenue category among related companies.
Search macroaxis.com